Advertisement

Index by author

September 01, 1993; Volume 44,Issue 3

A

  1. Afar, R

    1. Notice of retraction.
      M Quik, R Afar, S Geertsen, H el-Bizri, J M Trifaro, T Audhya and G Goldstein
      Molecular Pharmacology September 1993, 44 (3) 680; DOI: https://doi.org/10.1124/mol.44.3.680-a

  2. Agbunag, R V

    1. Role of the aryl hydrocarbon receptor nuclear translocator protein in aryl hydrocarbon (dioxin) receptor action.
      M R Probst, S Reisz-Porszasz, R V Agbunag, M S Ong and O Hankinson
      Molecular Pharmacology September 1993, 44 (3) 511-518;

  3. Ahluwalia, G S

    1. Enhanced stimulation by ribavirin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of purine 2'-beta-fluoro-2',3'-dideoxynucleosides.
      D G Johns, G S Ahluwalia, D A Cooney, H Mitsuya and J S Driscoll
      Molecular Pharmacology September 1993, 44 (3) 519-523;

  4. Anderson, R

    1. Lysophospholipid-mediated inhibition of Na+,K(+)-adenosine triphosphatase is a possible mechanism of immunosuppressive activity of cyclosporin A.
      R Anderson, M J Smit and C E Van Rensburg
      Molecular Pharmacology September 1993, 44 (3) 605-614;

  5. Audhya, T

    1. Notice of retraction.
      R J Lukas, L Lucero, T Audhya and G Goldstein
      Molecular Pharmacology September 1993, 44 (3) 680;
    2. Notice of retraction.
      M Quik, R Afar, S Geertsen, H el-Bizri, J M Trifaro, T Audhya and G Goldstein
      Molecular Pharmacology September 1993, 44 (3) 680; DOI: https://doi.org/10.1124/mol.44.3.680-a

B

  1. Barnes, P J

    1. Characterization of guinea pig pulmonary neurokinin type 1 receptors using a novel antagonist ligand, [3H]FK888.
      K Miyayasu, J C Mak, M Nishikawa and P J Barnes
      Molecular Pharmacology September 1993, 44 (3) 539-544;

  2. Beaumont, K

    1. High affinity amylin binding sites in rat brain.
      K Beaumont, M A Kenney, A A Young and T J Rink
      Molecular Pharmacology September 1993, 44 (3) 493-497;

  3. Bell, D

    1. Structural determinants of quaternary ammonium blockers for batrachotoxin-modified Na+ channels.
      G K Wang, R Simon, D Bell, W M Mok and S Y Wang
      Molecular Pharmacology September 1993, 44 (3) 667-676;

  4. Borden, L A

    1. Dual coupling of cloned human 5-hydroxytryptamine1D alpha and 5-hydroxytryptamine1D beta receptors stably expressed in murine fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s).
      J M Zgombick, L A Borden, T L Cochran, S A Kucharewicz, R L Weinshank and T A Branchek
      Molecular Pharmacology September 1993, 44 (3) 575-582;

  5. Branchek, T A

    1. Dual coupling of cloned human 5-hydroxytryptamine1D alpha and 5-hydroxytryptamine1D beta receptors stably expressed in murine fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s).
      J M Zgombick, L A Borden, T L Cochran, S A Kucharewicz, R L Weinshank and T A Branchek
      Molecular Pharmacology September 1993, 44 (3) 575-582;

  6. Brann, M R

    1. Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions.
      J Ellis, M Seidenberg and M R Brann
      Molecular Pharmacology September 1993, 44 (3) 583-588;

  7. Bresnick, E

    1. Rat CYP1A1 negative regulatory element: biological activity and interaction with a protein from liver and hepatoma cells.
      K Sterling, J Weaver, K L Ho, L C Xu and E Bresnick
      Molecular Pharmacology September 1993, 44 (3) 560-568;

  8. Brown, A M

    1. Verapamil blocks a rapidly activating delayed rectifier K+ channel cloned from human heart.
      D Rampe, B Wible, D Fedida, R C Dage and A M Brown
      Molecular Pharmacology September 1993, 44 (3) 642-648;

  9. Butcher, R W

    1. Beta 2-adrenergic receptor mutants reveal structural requirements for the desensitization observed with long-term epinephrine treatment.
      M A Proll, R B Clark and R W Butcher
      Molecular Pharmacology September 1993, 44 (3) 569-574;

C

  1. Castellano, M A

    1. Transfected D2 short dopamine receptors inhibit voltage-dependent potassium current in neuroblastoma x glioma hybrid (NG108-15) cells.
      M A Castellano, L X Liu, F J Monsma, D R Sibley, G Kapatos and L A Chiodo
      Molecular Pharmacology September 1993, 44 (3) 649-656;

  2. Chang, K J

    1. Alternative transcript of the nonselective-type endothelin receptor from rat brain.
      H F Cheng, Y M Su, J R Yeh and K J Chang
      Molecular Pharmacology September 1993, 44 (3) 533-538;

  3. Changeux, J P

    1. Presence of alpha-cobratoxin and phospholipase A2 activity in thymopoietin preparations.
      M Quik, R G Cook, F Revah, J P Changeux and J Patrick
      Molecular Pharmacology September 1993, 44 (3) 678-679;

  4. Cheng, H F

    1. Alternative transcript of the nonselective-type endothelin receptor from rat brain.
      H F Cheng, Y M Su, J R Yeh and K J Chang
      Molecular Pharmacology September 1993, 44 (3) 533-538;

  5. Chiodo, L A

    1. Transfected D2 short dopamine receptors inhibit voltage-dependent potassium current in neuroblastoma x glioma hybrid (NG108-15) cells.
      M A Castellano, L X Liu, F J Monsma, D R Sibley, G Kapatos and L A Chiodo
      Molecular Pharmacology September 1993, 44 (3) 649-656;

  6. Clark, R B

    1. Beta 2-adrenergic receptor mutants reveal structural requirements for the desensitization observed with long-term epinephrine treatment.
      M A Proll, R B Clark and R W Butcher
      Molecular Pharmacology September 1993, 44 (3) 569-574;

  7. Cochran, T L

    1. Dual coupling of cloned human 5-hydroxytryptamine1D alpha and 5-hydroxytryptamine1D beta receptors stably expressed in murine fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s).
      J M Zgombick, L A Borden, T L Cochran, S A Kucharewicz, R L Weinshank and T A Branchek
      Molecular Pharmacology September 1993, 44 (3) 575-582;

  8. Cook, R G

    1. Presence of alpha-cobratoxin and phospholipase A2 activity in thymopoietin preparations.
      M Quik, R G Cook, F Revah, J P Changeux and J Patrick
      Molecular Pharmacology September 1993, 44 (3) 678-679;

  9. Cooney, D A

    1. Enhanced stimulation by ribavirin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of purine 2'-beta-fluoro-2',3'-dideoxynucleosides.
      D G Johns, G S Ahluwalia, D A Cooney, H Mitsuya and J S Driscoll
      Molecular Pharmacology September 1993, 44 (3) 519-523;

D

  1. Dage, R C

    1. Verapamil blocks a rapidly activating delayed rectifier K+ channel cloned from human heart.
      D Rampe, B Wible, D Fedida, R C Dage and A M Brown
      Molecular Pharmacology September 1993, 44 (3) 642-648;

  2. Devane, W A

    1. Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells.
      K Mackie, W A Devane and B Hille
      Molecular Pharmacology September 1993, 44 (3) 498-503;

  3. Driscoll, J S

    1. Enhanced stimulation by ribavirin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of purine 2'-beta-fluoro-2',3'-dideoxynucleosides.
      D G Johns, G S Ahluwalia, D A Cooney, H Mitsuya and J S Driscoll
      Molecular Pharmacology September 1993, 44 (3) 519-523;

E

  1. Eiden, L E

    1. Enkephalin gene transcription in bovine chromaffin cells is regulated by calcium and protein kinase A signal transduction pathways: identification of DNase I-hypersensitive sites.
      L MacArthur, K J Koller and L E Eiden
      Molecular Pharmacology September 1993, 44 (3) 545-551;

  2. el-Bizri, H

    1. Notice of retraction.
      M Quik, R Afar, S Geertsen, H el-Bizri, J M Trifaro, T Audhya and G Goldstein
      Molecular Pharmacology September 1993, 44 (3) 680; DOI: https://doi.org/10.1124/mol.44.3.680-a

  3. Ellis, J

    1. Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions.
      J Ellis, M Seidenberg and M R Brann
      Molecular Pharmacology September 1993, 44 (3) 583-588;

F

  1. Fedida, D

    1. Verapamil blocks a rapidly activating delayed rectifier K+ channel cloned from human heart.
      D Rampe, B Wible, D Fedida, R C Dage and A M Brown
      Molecular Pharmacology September 1993, 44 (3) 642-648;

  2. Fink, J S

    1. Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution.
      J Linden, H E Taylor, A S Robeva, A L Tucker, J H Stehle, S A Rivkees, J S Fink and S M Reppert
      Molecular Pharmacology September 1993, 44 (3) 524-532;

G

  1. García-Sáinz, J A

    1. Characterization of the alpha 1A-adrenoceptors of guinea pig liver membranes: studies using 5-[3H]methylurapidil.
      J A García-Sáinz and M T Romero-Avila
      Molecular Pharmacology September 1993, 44 (3) 589-594;

  2. Geertsen, S

    1. Notice of retraction.
      M Quik, R Afar, S Geertsen, H el-Bizri, J M Trifaro, T Audhya and G Goldstein
      Molecular Pharmacology September 1993, 44 (3) 680; DOI: https://doi.org/10.1124/mol.44.3.680-a

  3. Goldstein, G

    1. Notice of retraction.
      R J Lukas, L Lucero, T Audhya and G Goldstein
      Molecular Pharmacology September 1993, 44 (3) 680;
    2. Notice of retraction.
      M Quik, R Afar, S Geertsen, H el-Bizri, J M Trifaro, T Audhya and G Goldstein
      Molecular Pharmacology September 1993, 44 (3) 680; DOI: https://doi.org/10.1124/mol.44.3.680-a

  4. Greenblatt, E P

    1. Positive modulation of human gamma-aminobutyric acid type A and glycine receptors by the inhalation anesthetic isoflurane.
      N L Harrison, J L Kugler, M V Jones, E P Greenblatt and D B Pritchett
      Molecular Pharmacology September 1993, 44 (3) 628-632;

H

  1. Hand, K

    1. Kinetic and equilibrium characterization of vesamicol receptor-ligand complexes with picomolar dissociation constants.
      G A Rogers, W D Kornreich, K Hand and S M Parsons
      Molecular Pharmacology September 1993, 44 (3) 633-641;

  2. Hankinson, O

    1. Role of the aryl hydrocarbon receptor nuclear translocator protein in aryl hydrocarbon (dioxin) receptor action.
      M R Probst, S Reisz-Porszasz, R V Agbunag, M S Ong and O Hankinson
      Molecular Pharmacology September 1993, 44 (3) 511-518;

  3. Harrison, N L

    1. Positive modulation of human gamma-aminobutyric acid type A and glycine receptors by the inhalation anesthetic isoflurane.
      N L Harrison, J L Kugler, M V Jones, E P Greenblatt and D B Pritchett
      Molecular Pharmacology September 1993, 44 (3) 628-632;

  4. Harwood, F C

    1. Pharmacological characterization of N-substituted phenoxazines directed toward reversing Vinca alkaloid resistance in multidrug-resistant cancer cells.
      J K Horton, K N Thimmaiah, F C Harwood, J F Kuttesch and P J Houghton
      Molecular Pharmacology September 1993, 44 (3) 552-559;

  5. Hille, B

    1. Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells.
      K Mackie, W A Devane and B Hille
      Molecular Pharmacology September 1993, 44 (3) 498-503;

  6. Ho, K L

    1. Rat CYP1A1 negative regulatory element: biological activity and interaction with a protein from liver and hepatoma cells.
      K Sterling, J Weaver, K L Ho, L C Xu and E Bresnick
      Molecular Pharmacology September 1993, 44 (3) 560-568;

  7. Horton, J K

    1. Pharmacological characterization of N-substituted phenoxazines directed toward reversing Vinca alkaloid resistance in multidrug-resistant cancer cells.
      J K Horton, K N Thimmaiah, F C Harwood, J F Kuttesch and P J Houghton
      Molecular Pharmacology September 1993, 44 (3) 552-559;

  8. Houghton, P J

    1. Pharmacological characterization of N-substituted phenoxazines directed toward reversing Vinca alkaloid resistance in multidrug-resistant cancer cells.
      J K Horton, K N Thimmaiah, F C Harwood, J F Kuttesch and P J Houghton
      Molecular Pharmacology September 1993, 44 (3) 552-559;

J

  1. Johns, D G

    1. Enhanced stimulation by ribavirin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of purine 2'-beta-fluoro-2',3'-dideoxynucleosides.
      D G Johns, G S Ahluwalia, D A Cooney, H Mitsuya and J S Driscoll
      Molecular Pharmacology September 1993, 44 (3) 519-523;

  2. Jones, M V

    1. Positive modulation of human gamma-aminobutyric acid type A and glycine receptors by the inhalation anesthetic isoflurane.
      N L Harrison, J L Kugler, M V Jones, E P Greenblatt and D B Pritchett
      Molecular Pharmacology September 1993, 44 (3) 628-632;

K

  1. Kapatos, G

    1. Transfected D2 short dopamine receptors inhibit voltage-dependent potassium current in neuroblastoma x glioma hybrid (NG108-15) cells.
      M A Castellano, L X Liu, F J Monsma, D R Sibley, G Kapatos and L A Chiodo
      Molecular Pharmacology September 1993, 44 (3) 649-656;

  2. Kenney, M A

    1. High affinity amylin binding sites in rat brain.
      K Beaumont, M A Kenney, A A Young and T J Rink
      Molecular Pharmacology September 1993, 44 (3) 493-497;

  3. Klatt, P

    1. Characterization of endothelial cell amino acid transport systems involved in the actions of nitric oxide synthase inhibitors.
      K Schmidt, P Klatt and B Mayer
      Molecular Pharmacology September 1993, 44 (3) 615-621;

  4. Koller, K J

    1. Enkephalin gene transcription in bovine chromaffin cells is regulated by calcium and protein kinase A signal transduction pathways: identification of DNase I-hypersensitive sites.
      L MacArthur, K J Koller and L E Eiden
      Molecular Pharmacology September 1993, 44 (3) 545-551;

  5. Kornreich, W D

    1. Kinetic and equilibrium characterization of vesamicol receptor-ligand complexes with picomolar dissociation constants.
      G A Rogers, W D Kornreich, K Hand and S M Parsons
      Molecular Pharmacology September 1993, 44 (3) 633-641;

  6. Kucharewicz, S A

    1. Dual coupling of cloned human 5-hydroxytryptamine1D alpha and 5-hydroxytryptamine1D beta receptors stably expressed in murine fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s).
      J M Zgombick, L A Borden, T L Cochran, S A Kucharewicz, R L Weinshank and T A Branchek
      Molecular Pharmacology September 1993, 44 (3) 575-582;

  7. Kugler, J L

    1. Positive modulation of human gamma-aminobutyric acid type A and glycine receptors by the inhalation anesthetic isoflurane.
      N L Harrison, J L Kugler, M V Jones, E P Greenblatt and D B Pritchett
      Molecular Pharmacology September 1993, 44 (3) 628-632;

  8. Kuttesch, J F

    1. Pharmacological characterization of N-substituted phenoxazines directed toward reversing Vinca alkaloid resistance in multidrug-resistant cancer cells.
      J K Horton, K N Thimmaiah, F C Harwood, J F Kuttesch and P J Houghton
      Molecular Pharmacology September 1993, 44 (3) 552-559;

L

  1. Linden, J

    1. Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution.
      J Linden, H E Taylor, A S Robeva, A L Tucker, J H Stehle, S A Rivkees, J S Fink and S M Reppert
      Molecular Pharmacology September 1993, 44 (3) 524-532;

  2. Liu, L X

    1. Transfected D2 short dopamine receptors inhibit voltage-dependent potassium current in neuroblastoma x glioma hybrid (NG108-15) cells.
      M A Castellano, L X Liu, F J Monsma, D R Sibley, G Kapatos and L A Chiodo
      Molecular Pharmacology September 1993, 44 (3) 649-656;

  3. Lucero, L

    1. Notice of retraction.
      R J Lukas, L Lucero, T Audhya and G Goldstein
      Molecular Pharmacology September 1993, 44 (3) 680;

  4. Luetje, C W

    1. Mapping of ligand binding sites of neuronal nicotinic acetylcholine receptors using chimeric alpha subunits.
      C W Luetje, M Piattoni and J Patrick
      Molecular Pharmacology September 1993, 44 (3) 657-666;

  5. Lukas, R J

    1. Notice of retraction.
      R J Lukas, L Lucero, T Audhya and G Goldstein
      Molecular Pharmacology September 1993, 44 (3) 680;

M

  1. MacArthur, L

    1. Enkephalin gene transcription in bovine chromaffin cells is regulated by calcium and protein kinase A signal transduction pathways: identification of DNase I-hypersensitive sites.
      L MacArthur, K J Koller and L E Eiden
      Molecular Pharmacology September 1993, 44 (3) 545-551;

  2. Mackie, K

    1. Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells.
      K Mackie, W A Devane and B Hille
      Molecular Pharmacology September 1993, 44 (3) 498-503;

  3. Mak, J C

    1. Characterization of guinea pig pulmonary neurokinin type 1 receptors using a novel antagonist ligand, [3H]FK888.
      K Miyayasu, J C Mak, M Nishikawa and P J Barnes
      Molecular Pharmacology September 1993, 44 (3) 539-544;

  4. Mayer, B

    1. Characterization of endothelial cell amino acid transport systems involved in the actions of nitric oxide synthase inhibitors.
      K Schmidt, P Klatt and B Mayer
      Molecular Pharmacology September 1993, 44 (3) 615-621;

  5. Mayer, M L

    1. Differential modulation by cyclothiazide and concanavalin A of desensitization at native alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid- and kainate-preferring glutamate receptors.
      L A Wong and M L Mayer
      Molecular Pharmacology September 1993, 44 (3) 504-510;

  6. Mitsuya, H

    1. Enhanced stimulation by ribavirin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of purine 2'-beta-fluoro-2',3'-dideoxynucleosides.
      D G Johns, G S Ahluwalia, D A Cooney, H Mitsuya and J S Driscoll
      Molecular Pharmacology September 1993, 44 (3) 519-523;

  7. Miyayasu, K

    1. Characterization of guinea pig pulmonary neurokinin type 1 receptors using a novel antagonist ligand, [3H]FK888.
      K Miyayasu, J C Mak, M Nishikawa and P J Barnes
      Molecular Pharmacology September 1993, 44 (3) 539-544;

  8. Mok, W M

    1. Structural determinants of quaternary ammonium blockers for batrachotoxin-modified Na+ channels.
      G K Wang, R Simon, D Bell, W M Mok and S Y Wang
      Molecular Pharmacology September 1993, 44 (3) 667-676;

  9. Monsma, F J

    1. Transfected D2 short dopamine receptors inhibit voltage-dependent potassium current in neuroblastoma x glioma hybrid (NG108-15) cells.
      M A Castellano, L X Liu, F J Monsma, D R Sibley, G Kapatos and L A Chiodo
      Molecular Pharmacology September 1993, 44 (3) 649-656;

N

  1. Nishikawa, M

    1. Characterization of guinea pig pulmonary neurokinin type 1 receptors using a novel antagonist ligand, [3H]FK888.
      K Miyayasu, J C Mak, M Nishikawa and P J Barnes
      Molecular Pharmacology September 1993, 44 (3) 539-544;

O

  1. Ong, M S

    1. Role of the aryl hydrocarbon receptor nuclear translocator protein in aryl hydrocarbon (dioxin) receptor action.
      M R Probst, S Reisz-Porszasz, R V Agbunag, M S Ong and O Hankinson
      Molecular Pharmacology September 1993, 44 (3) 511-518;

  2. Otero, A de S

    1. Benzoquinoid tyrosine kinase inhibitors are potent blockers of cardiac muscarinic receptor function.
      A de S Otero and N M Sweitzer
      Molecular Pharmacology September 1993, 44 (3) 595-604;

P

  1. Parsons, S M

    1. Kinetic and equilibrium characterization of vesamicol receptor-ligand complexes with picomolar dissociation constants.
      G A Rogers, W D Kornreich, K Hand and S M Parsons
      Molecular Pharmacology September 1993, 44 (3) 633-641;

  2. Patrick, J

    1. Mapping of ligand binding sites of neuronal nicotinic acetylcholine receptors using chimeric alpha subunits.
      C W Luetje, M Piattoni and J Patrick
      Molecular Pharmacology September 1993, 44 (3) 657-666;
    2. Presence of alpha-cobratoxin and phospholipase A2 activity in thymopoietin preparations.
      M Quik, R G Cook, F Revah, J P Changeux and J Patrick
      Molecular Pharmacology September 1993, 44 (3) 678-679;

  3. Piattoni, M

    1. Mapping of ligand binding sites of neuronal nicotinic acetylcholine receptors using chimeric alpha subunits.
      C W Luetje, M Piattoni and J Patrick
      Molecular Pharmacology September 1993, 44 (3) 657-666;

  4. Pritchett, D B

    1. Positive modulation of human gamma-aminobutyric acid type A and glycine receptors by the inhalation anesthetic isoflurane.
      N L Harrison, J L Kugler, M V Jones, E P Greenblatt and D B Pritchett
      Molecular Pharmacology September 1993, 44 (3) 628-632;

  5. Probst, M R

    1. Role of the aryl hydrocarbon receptor nuclear translocator protein in aryl hydrocarbon (dioxin) receptor action.
      M R Probst, S Reisz-Porszasz, R V Agbunag, M S Ong and O Hankinson
      Molecular Pharmacology September 1993, 44 (3) 511-518;

  6. Proll, M A

    1. Beta 2-adrenergic receptor mutants reveal structural requirements for the desensitization observed with long-term epinephrine treatment.
      M A Proll, R B Clark and R W Butcher
      Molecular Pharmacology September 1993, 44 (3) 569-574;

Q

  1. Quik, M

    1. Presence of alpha-cobratoxin and phospholipase A2 activity in thymopoietin preparations.
      M Quik, R G Cook, F Revah, J P Changeux and J Patrick
      Molecular Pharmacology September 1993, 44 (3) 678-679;
    2. Notice of retraction.
      M Quik, R Afar, S Geertsen, H el-Bizri, J M Trifaro, T Audhya and G Goldstein
      Molecular Pharmacology September 1993, 44 (3) 680; DOI: https://doi.org/10.1124/mol.44.3.680-a

R

  1. Rampe, D

    1. Verapamil blocks a rapidly activating delayed rectifier K+ channel cloned from human heart.
      D Rampe, B Wible, D Fedida, R C Dage and A M Brown
      Molecular Pharmacology September 1993, 44 (3) 642-648;

  2. Reisz-Porszasz, S

    1. Role of the aryl hydrocarbon receptor nuclear translocator protein in aryl hydrocarbon (dioxin) receptor action.
      M R Probst, S Reisz-Porszasz, R V Agbunag, M S Ong and O Hankinson
      Molecular Pharmacology September 1993, 44 (3) 511-518;

  3. Reppert, S M

    1. Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution.
      J Linden, H E Taylor, A S Robeva, A L Tucker, J H Stehle, S A Rivkees, J S Fink and S M Reppert
      Molecular Pharmacology September 1993, 44 (3) 524-532;

  4. Revah, F

    1. Presence of alpha-cobratoxin and phospholipase A2 activity in thymopoietin preparations.
      M Quik, R G Cook, F Revah, J P Changeux and J Patrick
      Molecular Pharmacology September 1993, 44 (3) 678-679;

  5. Rink, T J

    1. High affinity amylin binding sites in rat brain.
      K Beaumont, M A Kenney, A A Young and T J Rink
      Molecular Pharmacology September 1993, 44 (3) 493-497;

  6. Rivkees, S A

    1. Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution.
      J Linden, H E Taylor, A S Robeva, A L Tucker, J H Stehle, S A Rivkees, J S Fink and S M Reppert
      Molecular Pharmacology September 1993, 44 (3) 524-532;

  7. Robeva, A S

    1. Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution.
      J Linden, H E Taylor, A S Robeva, A L Tucker, J H Stehle, S A Rivkees, J S Fink and S M Reppert
      Molecular Pharmacology September 1993, 44 (3) 524-532;

  8. Rogers, G A

    1. Kinetic and equilibrium characterization of vesamicol receptor-ligand complexes with picomolar dissociation constants.
      G A Rogers, W D Kornreich, K Hand and S M Parsons
      Molecular Pharmacology September 1993, 44 (3) 633-641;

  9. Romero-Avila, M T

    1. Characterization of the alpha 1A-adrenoceptors of guinea pig liver membranes: studies using 5-[3H]methylurapidil.
      J A García-Sáinz and M T Romero-Avila
      Molecular Pharmacology September 1993, 44 (3) 589-594;

S

  1. Schmidt, K

    1. Characterization of endothelial cell amino acid transport systems involved in the actions of nitric oxide synthase inhibitors.
      K Schmidt, P Klatt and B Mayer
      Molecular Pharmacology September 1993, 44 (3) 615-621;

  2. Seidenberg, M

    1. Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions.
      J Ellis, M Seidenberg and M R Brann
      Molecular Pharmacology September 1993, 44 (3) 583-588;

  3. Sibley, D R

    1. Transfected D2 short dopamine receptors inhibit voltage-dependent potassium current in neuroblastoma x glioma hybrid (NG108-15) cells.
      M A Castellano, L X Liu, F J Monsma, D R Sibley, G Kapatos and L A Chiodo
      Molecular Pharmacology September 1993, 44 (3) 649-656;

  4. Simasko, S M

    1. 3-Isobutyl-1-methylxanthine inhibits sustained calcium current independently of cyclic AMP in neuronal and endocrine cells.
      S M Simasko and S Yan
      Molecular Pharmacology September 1993, 44 (3) 622-627;

  5. Simon, R

    1. Structural determinants of quaternary ammonium blockers for batrachotoxin-modified Na+ channels.
      G K Wang, R Simon, D Bell, W M Mok and S Y Wang
      Molecular Pharmacology September 1993, 44 (3) 667-676;

  6. Smit, M J

    1. Lysophospholipid-mediated inhibition of Na+,K(+)-adenosine triphosphatase is a possible mechanism of immunosuppressive activity of cyclosporin A.
      R Anderson, M J Smit and C E Van Rensburg
      Molecular Pharmacology September 1993, 44 (3) 605-614;

  7. Stehle, J H

    1. Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution.
      J Linden, H E Taylor, A S Robeva, A L Tucker, J H Stehle, S A Rivkees, J S Fink and S M Reppert
      Molecular Pharmacology September 1993, 44 (3) 524-532;

  8. Sterling, K

    1. Rat CYP1A1 negative regulatory element: biological activity and interaction with a protein from liver and hepatoma cells.
      K Sterling, J Weaver, K L Ho, L C Xu and E Bresnick
      Molecular Pharmacology September 1993, 44 (3) 560-568;

  9. Su, Y M

    1. Alternative transcript of the nonselective-type endothelin receptor from rat brain.
      H F Cheng, Y M Su, J R Yeh and K J Chang
      Molecular Pharmacology September 1993, 44 (3) 533-538;

  10. Sweitzer, N M

    1. Benzoquinoid tyrosine kinase inhibitors are potent blockers of cardiac muscarinic receptor function.
      A de S Otero and N M Sweitzer
      Molecular Pharmacology September 1993, 44 (3) 595-604;

T

  1. Taylor, H E

    1. Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution.
      J Linden, H E Taylor, A S Robeva, A L Tucker, J H Stehle, S A Rivkees, J S Fink and S M Reppert
      Molecular Pharmacology September 1993, 44 (3) 524-532;

  2. Thimmaiah, K N

    1. Pharmacological characterization of N-substituted phenoxazines directed toward reversing Vinca alkaloid resistance in multidrug-resistant cancer cells.
      J K Horton, K N Thimmaiah, F C Harwood, J F Kuttesch and P J Houghton
      Molecular Pharmacology September 1993, 44 (3) 552-559;

  3. Trifaro, J M

    1. Notice of retraction.
      M Quik, R Afar, S Geertsen, H el-Bizri, J M Trifaro, T Audhya and G Goldstein
      Molecular Pharmacology September 1993, 44 (3) 680; DOI: https://doi.org/10.1124/mol.44.3.680-a

  4. Tucker, A L

    1. Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution.
      J Linden, H E Taylor, A S Robeva, A L Tucker, J H Stehle, S A Rivkees, J S Fink and S M Reppert
      Molecular Pharmacology September 1993, 44 (3) 524-532;

V

  1. Van Rensburg, C E

    1. Lysophospholipid-mediated inhibition of Na+,K(+)-adenosine triphosphatase is a possible mechanism of immunosuppressive activity of cyclosporin A.
      R Anderson, M J Smit and C E Van Rensburg
      Molecular Pharmacology September 1993, 44 (3) 605-614;

W

  1. Wang, G K

    1. Structural determinants of quaternary ammonium blockers for batrachotoxin-modified Na+ channels.
      G K Wang, R Simon, D Bell, W M Mok and S Y Wang
      Molecular Pharmacology September 1993, 44 (3) 667-676;

  2. Wang, S Y

    1. Structural determinants of quaternary ammonium blockers for batrachotoxin-modified Na+ channels.
      G K Wang, R Simon, D Bell, W M Mok and S Y Wang
      Molecular Pharmacology September 1993, 44 (3) 667-676;

  3. Weaver, J

    1. Rat CYP1A1 negative regulatory element: biological activity and interaction with a protein from liver and hepatoma cells.
      K Sterling, J Weaver, K L Ho, L C Xu and E Bresnick
      Molecular Pharmacology September 1993, 44 (3) 560-568;

  4. Weinshank, R L

    1. Dual coupling of cloned human 5-hydroxytryptamine1D alpha and 5-hydroxytryptamine1D beta receptors stably expressed in murine fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s).
      J M Zgombick, L A Borden, T L Cochran, S A Kucharewicz, R L Weinshank and T A Branchek
      Molecular Pharmacology September 1993, 44 (3) 575-582;

  5. Wible, B

    1. Verapamil blocks a rapidly activating delayed rectifier K+ channel cloned from human heart.
      D Rampe, B Wible, D Fedida, R C Dage and A M Brown
      Molecular Pharmacology September 1993, 44 (3) 642-648;

  6. Wong, L A

    1. Differential modulation by cyclothiazide and concanavalin A of desensitization at native alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid- and kainate-preferring glutamate receptors.
      L A Wong and M L Mayer
      Molecular Pharmacology September 1993, 44 (3) 504-510;

X

  1. Xu, L C

    1. Rat CYP1A1 negative regulatory element: biological activity and interaction with a protein from liver and hepatoma cells.
      K Sterling, J Weaver, K L Ho, L C Xu and E Bresnick
      Molecular Pharmacology September 1993, 44 (3) 560-568;

Y

  1. Yan, S

    1. 3-Isobutyl-1-methylxanthine inhibits sustained calcium current independently of cyclic AMP in neuronal and endocrine cells.
      S M Simasko and S Yan
      Molecular Pharmacology September 1993, 44 (3) 622-627;

  2. Yeh, J R

    1. Alternative transcript of the nonselective-type endothelin receptor from rat brain.
      H F Cheng, Y M Su, J R Yeh and K J Chang
      Molecular Pharmacology September 1993, 44 (3) 533-538;

  3. Young, A A

    1. High affinity amylin binding sites in rat brain.
      K Beaumont, M A Kenney, A A Young and T J Rink
      Molecular Pharmacology September 1993, 44 (3) 493-497;

Z

  1. Zgombick, J M

    1. Dual coupling of cloned human 5-hydroxytryptamine1D alpha and 5-hydroxytryptamine1D beta receptors stably expressed in murine fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s).
      J M Zgombick, L A Borden, T L Cochran, S A Kucharewicz, R L Weinshank and T A Branchek
      Molecular Pharmacology September 1993, 44 (3) 575-582;
Back to top

In this issue